- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02519023
TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy
Transversus Abdominis Plane (TAP) Infiltration vs. Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Assisted Hysterectomy
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
This is a double blinded randomized study. All patients will receive one form of local anesthetic pain relief either from TAP or infiltration. Patients will be randomized to one of two study arms in a double-blinded, placebo controlled study. All patients will receive a TAP infiltration and all patients will receive infiltration into the incision.
In one arm the TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline. This will then be repeated on the contralateral side. In the same arm the surgeon infiltration into the incision will consist of 10 ml of normal saline per port site, 5 ml prior to incision and 5 ml prior to closure at each port site.
In the second arm the bilateral TAP infiltration will consist of 30 mL of normal saline per side. In the same arm the surgeon infiltration will consist of 10 mL of 0.25% bupivacaine per port site. The surgeon infiltration will consist of 5 ml of 0.25% bupivacaine prior to incision and 5 ml of 0.25% bupivacaine prior to closure at each port site.
A TAP infiltration is an injection of local anesthetic under the covering of the transversus abdominis muscle layer which provides effective post operative analgesia.2-5 This layer is found using an ultrasound, which is a beam of high frequency sound that allows one to visualize images in the body. Then using this ultrasound the investigators can see our needle as it pierces the covering of the transversus abdominis muscle layer and watch as the local anesthetic is infiltrated into this plane. This is done on both sides of the abdomen to provide analgesia to the skin, muscle, and facial layers of the abdomen. This is currently standard of care at our institution and will be performed within one hour of surgical incision. The injection will consist of 10 mL of 0.25% bupivacaine with epinephrine followed by 20 mL of liposomal bupivacaine saline mixture or 10 ml of saline followed by 20 ml of saline and then repeated on the contralateral side.
Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions. At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions.
Investigational Drug Service (IDS) pharmacy will be charged with the blinding of medications vs. saline for these procedures.
Following the procedure, all individuals will receive scheduled acetaminophen (1 gram every 6 hours), scheduled ibuprofen (800 mg every 8 hours), and PRN oxycodone 5-10mg q4h if pain is rated at more than 5 out of 10 on a numerical pain scale.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 4
Contatti e Sedi
Luoghi di studio
-
-
Minnesota
-
Minneapolis, Minnesota, Stati Uniti, 55455
- University of Minnesota
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- ASA physical status I-III
- Females >/=18-years of age
- Scheduled for laparoscopic/robot-assisted hysterectomy.
Exclusion Criteria
- Contraindication to surgical infiltration or regional blockade
- History of long term opioid intake (greater than 3 weeks prior to surgery) or chronic pain disorder
- Inability to understand the informed consent and demands of the study
- Surgery scheduled to start after 1700
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Quadruplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: TAP-Block with liposomal bupivacaine
TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline.
This will then be repeated on the contralateral side.
In the same arm the surgeon infiltration into the incision will consist of 10 ml of normal saline per port site, 5 ml prior to incision and 5 ml prior to closure at each port site.
|
In one arm the TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine injected followed by 20 mL of a 50:50 mixture of liposomal bupivacaine and normal saline.
This will then be repeated on the contralateral side.
Altri nomi:
An ultrasound, which is a beam of high frequency sound that allows one to visualize images in the body, will be used to aid investigators to observe the local anesthetic being infiltrated into the plane
TAP infiltration will contain 10 mL of 0.25 % bupivacaine with epinephrine.
all individuals will receive scheduled acetaminophen (1 gram every 6 hours),
all individuals will receive scheduled ibuprofen (800 mg every 8 hours)
all individuals will receive PRN oxycodone 5-10mg q4h if pain is rated at more than 5 out of 10 on a numerical pain scale.
|
|
Comparatore attivo: Surgical infiltration with bupivacaine
Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions.
At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions.
|
An ultrasound, which is a beam of high frequency sound that allows one to visualize images in the body, will be used to aid investigators to observe the local anesthetic being infiltrated into the plane
all individuals will receive scheduled acetaminophen (1 gram every 6 hours),
all individuals will receive scheduled ibuprofen (800 mg every 8 hours)
all individuals will receive PRN oxycodone 5-10mg q4h if pain is rated at more than 5 out of 10 on a numerical pain scale.
Surgical Infiltration of the study solution will be performed both prior to incision and at the end of surgery just prior to closure of incisions.
At each time, the surgeon will inject 5 mL of 0.25% bupivacaine into each of the port site incisions.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Total Opioid Use for Pain Control
Lasso di tempo: 72 hours
|
total opioid used from time 0 after surgery through 72 hours after surgery was complete.
|
72 hours
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Maximum Pain Scores as Measured by Numerical Pain Rating Scale (0-10)
Lasso di tempo: 0-72 hours post-procedure
|
the Numerical rating scale goes from 0 (lowest) to 10 (highest).
Higher values are a worse outcome.
The maximal number for maximal pain scores from 0-72 hours is 30.
Thus the range for this outcome is 0 to 30 with 30 being a worse outcome.
This is because the 0-72 hour maximal pain scores are additive from the 0-24, 24-48, and 48-72 hours.
Each 24 hour subset has a maximal score of 10 and adding all three results in maximal score of 30.
|
0-72 hours post-procedure
|
|
Total Opioid Taken by Patient as Tabulated and Converted to Morphine Equivalents
Lasso di tempo: 0-24 post-procedure
|
0-24 post-procedure
|
|
|
Quality of Recovery 15 (QoR15) Score
Lasso di tempo: 72 hours post-procedure
|
The quality of recovery is a survey given to patients.
It is 15 questions.
The scale of the QOR 15 Score is 0 to 150. 150 is a better outcome.
|
72 hours post-procedure
|
|
Overall Benefit of Analgesia Score (OBAS)
Lasso di tempo: 72 hours post-procedure
|
The overall benefit of analgesia score is based off 7 questions given to patients it is scored 0-28.
28 is considered a worse outcome.
|
72 hours post-procedure
|
|
Number of Participants With Nausea and Vomiting
Lasso di tempo: 72 hours post-procedure
|
72 hours post-procedure
|
|
|
Length of Time in Phase 1 and Phase 2 of Recovery
Lasso di tempo: an expected average of 120 mins
|
time from start of recovery until patient was deemed ready to discharge from phase 2 recovery.
Phase 2 recovery is the phase of the post anesthesia care where patients are readied to be discharge form the post anesthesia care unit.
There are guidelines with regards to when patients are able to be discharged and when those points are met by the patient they are deemed ready to discharge.
|
an expected average of 120 mins
|
|
Number of Patients Admitted Post Operatively
Lasso di tempo: 72 hours post-procedure
|
72 hours post-procedure
|
|
|
Opioid Used From 24-48 Hours Post Surgery
Lasso di tempo: 24-48 hours after the end of surgery
|
opioids in mg of morphine equivalents used from 24-48 hours after surgery
|
24-48 hours after the end of surgery
|
|
Total Opioid Taken by Patient as Tabulated and Converted to Morphine Equivalents
Lasso di tempo: 48-72 hours after end of surgery
|
opioid use from time 48-72 hours in mg morphine equivalents
|
48-72 hours after end of surgery
|
|
Patient Satisfaction With Pain Management
Lasso di tempo: at 72 hours after surgery
|
number of patients who answered yes to if they were satisfied with their pain management
|
at 72 hours after surgery
|
|
Maximal Pain Score of Patient From Time 0-24 Hours After Surgery
Lasso di tempo: 0-24 hours after surgery
|
the maximal pain score felt by patient during this time period.
This is based on a numerical rating scale of 0-10.
0 is best outcome and 10 is worst outcome.
|
0-24 hours after surgery
|
|
Maximal Pain Score for Patient From Time 24-48 Hours After Surgery
Lasso di tempo: 24-48 hours after surgery
|
the maximal pain score felt by patient during this time period.
This is based on a numerical rating scale of 0-10.
0 is best outcome and 10 is worst outcome.
|
24-48 hours after surgery
|
|
Maximal Pain Score Patient Felt From 48-72 Hours After Surgery
Lasso di tempo: 48-72 hours after surgery
|
the maximal pain score felt by patient during this time period.
This is based on a numerical rating scale of 0-10.
0 is best outcome and 10 is worst outcome.
|
48-72 hours after surgery
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Niraj G, Searle A, Mathews M, Misra V, Baban M, Kiani S, Wong M. Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth. 2009 Oct;103(4):601-5. doi: 10.1093/bja/aep175. Epub 2009 Jun 26.
- Petersen PL, Mathiesen O, Torup H, Dahl JB. The transversus abdominis plane block: a valuable option for postoperative analgesia? A topical review. Acta Anaesthesiol Scand. 2010 May;54(5):529-35. doi: 10.1111/j.1399-6576.2010.02215.x. Epub 2010 Feb 17.
- Feierman DE, Kronenfeld M, Gupta PM, Younger N, Logvinskiy E. Liposomal bupivacaine infiltration into the transversus abdominis plane for postsurgical analgesia in open abdominal umbilical hernia repair: results from a cohort of 13 patients. J Pain Res. 2014 Aug 16;7:477-82. doi: 10.2147/JPR.S65151. eCollection 2014.
- Mitchell AU, Torup H, Hansen EG, Petersen PL, Mathiesen O, Dahl JB, Rosenberg J, Moller AM. Effective dermatomal blockade after subcostal transversus abdominis plane block. Dan Med J. 2012 Mar;59(3):A4404.
- Singh M, Chin KJ, Chan V. Ultrasound-guided transversus abdominis plane (TAP) block: a useful adjunct in the management of postoperative respiratory failure. J Clin Anesth. 2011 Jun;23(4):303-6. doi: 10.1016/j.jclinane.2010.05.012.
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Dolore
- Manifestazioni neurologiche
- Dolore acuto
- Effetti fisiologici delle droghe
- Agenti adrenergici
- Agenti neurotrasmettitori
- Meccanismi molecolari dell'azione farmacologica
- Depressori del sistema nervoso centrale
- Agenti autonomi
- Agenti del sistema nervoso periferico
- Inibitori enzimatici
- Analgesici
- Agenti del sistema sensoriale
- Anestetici
- Agenti antinfiammatori, non steroidei
- Analgesici, non narcotici
- Agenti antinfiammatori
- Agenti antireumatici
- Inibitori della ciclossigenasi
- Antipiretici
- Alfa-agonisti adrenergici
- Agonisti adrenergici
- Analgesici, oppioidi
- Narcotici
- Anestetici, Locali
- Agenti broncodilatatori
- Agenti antiasmatici
- Agenti del sistema respiratorio
- Beta-agonisti adrenergici
- Simpaticomimetici
- Agenti vasocostrittori
- Midriatici
- Acetaminofene
- Bupivacaina
- Ibuprofene
- Epinefrina
- Ossicodone
Altri numeri di identificazione dello studio
- 7152222222
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Dolore acuto
-
Cairo UniversityCompletatoSCOPO PAIN (VAS) a 24 ore dopo l'interventoEgitto
-
University of OklahomaThe Children's Hospital at OU Medical CenterCompletatoDolore addominale funzionale | Crisi falciforme | Pazienti seguiti dal Pain Team
-
Fenerbahce UniversityIscrizione su invitoUstioni acuteTurchia (Türkiye)
-
People's Hospital of Guangxi Zhuang Autonomous...CompletatoLesioni polmonari acute (ALI)Cina
-
BioMérieuxReclutamentoInfezioni respiratorie acute (ARI)Stati Uniti
-
Lumos DiagnosticsReclutamento
-
Tam Anh Research InstituteReclutamentoInfezioni respiratorie acute (ARI)Vietnam
-
Lohmann & RauscherReclutamentoFerite acute e cronicheGermania
-
MMSx Authority Institute for Movement Mechanics...CompletatoDolore muscoloscheletrico - Condizioni acute e subacuteStati Uniti, India
-
Aswan UniversityIscrizione su invitoDiagnosi precoce di lesioni renali acuteEgitto
Prove cliniche su Liposomal Bupivacaine
-
Aronex PharmaceuticalsSconosciuto
-
Ain Shams UniversityCompletatoDolore durante il posizionamento spinaleEgitto
-
Indonesia UniversityCompletatoOperazione al ginocchio | Chirurgia pelvica | Anestesia spinaleIndonesia
-
Ain Shams UniversityCompletatoChirurgia artroscopica della spalla | Dolore postoperatorio, acutoEgitto
-
University Hospitals Cleveland Medical CenterReclutamento
-
Yasser S Mostafa, MDReclutamento
-
Recep Tayyip Erdogan Hospital PakistanCompletatoColecistectomia laparoscopica | Analgesia postoperatoria | BupivacainaPakistan
-
Başakşehir Çam & Sakura City HospitalCompletatoConsumo di oppioidi | Dolore postoperatorioTacchino
-
University Clinic for Anesthesia Reanimation and...CompletatoAnestesiaMacedonia, ex Repubblica iugoslava di
-
Holger JoswigCompletatoErnia del disco lombare | Ernia del disco cervicaleSvizzera